Korea Arlico Pharm Co Ltd
KOSDAQ:260660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Korea Arlico Pharm Co Ltd
KOSDAQ:260660
|
KR |
|
G
|
Gentherm Inc
F:QA4A
|
US |
|
M
|
MTU Aero Engines AG
F:MTX
|
DE |
|
Siemens AG
F:SIE
|
DE |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Korea Arlico Pharm Co Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Korea Arlico Pharm Does
Korea Arlico Pharm Co., Ltd. engages in the provision of development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 228 full-time employees. The company went IPO on 2018-02-12. The firm manufactures and sells medicines such as hyperlipidemia, cerebrovascular disease, digestive medicine, allergies, respiratory medicine and others. In addition, the Company is also engaged in the manufacture of non-pharmaceutical products such as sun cream, hand cream and medical devices. The firm sells its products in domestic and overseas markets.
- Headquarters
- Korea KR
- Employees
- 228
- IPO date
- Feb 12, 2018